MOXY Hi-Res Medical 3D Printing (1)
Melt Electrowriting (MEW)
Advanced 3D printing technology producing high-resolution complex, fibrous structures.
Electro-centrifugal Spinning
High-efficiency nanofiber fabrication technology producing highly aligned high-strength fibers.
Melt Spinning for R&D
High-efficiency filament fabrication technology requiring only 30 grams of polymer per batch, suitable for R&D of medical devices. The system consists of a mini extruder, spinning die and winding machine.
Braiding
Braiding designed structures including flow-diverting stents.
What is MOXY?
MOXY is the company developing the cutting-edge 3D printing technologies dedicated to medical device manufacturing, launched as a university R&D-based startup founded by researchers and engineers working at Kyoto Institute of Technology (KIT), Japan in 2025.
| Company name | MOXY Co., Ltd. |
|---|---|
| Website | https://moxy-tech.co.jp/ |
| CEO | Hitomi Ohara |
| Year founded | 2025 |
| Founder | Hitomi Ohara, Huaizhong Xu, Shinichi Yagi |
For the details of the 3D printing technologies, please see MOXY’s website.
BMG cooperates with MOXY for manufacturing medical devices having high-resolution complex, fibrous structures by providing MOXY’s 3D printers with bioabsorbable BioDegmer polymers such as PLLA, PCL and PGLA. They are tuned for the printers and performances of the 3D-printed products.
Prototyping/manufacturing process for medical device and regenerative medicine applications
We exclusively accept prototyping and manufacturing requests for medical device and regenerative medicine applications using MOXY’s 3D printing technology. We offer custom products by providing total support from material selection, design, modeling to evaluation to meet the needs of researchers and developers.
1. Inquiry
Contact us to give shape to your needs for medical, regenerative medicine device and tissue engineering applications.
2. Consulting and design
We propose optimal material and structural design considering target properties required in your application.
3. Prototyping
We fabricate prototypes using BioDegmer polymers and MOXY's high-resolution 3D printers.
4. Evaluation and feedbacks
Upon request, we can provide support for physical property evaluations and cell culture tests.
5. Expanding to joint R&D/mass production
Based on the evaluation results of prototyping, we are ready to proceed to academic/industrial joint research and/or mass production.
Inquiry desk
Business Planning Group, BMG Incorporated
Email : business@bmg-inc.com
Phone: +81 (0)75 681 0787 (Japan)
BMG provides exclusive support for medical device and regenerative medicine applications based on the partnership with MOXY.
BMG Inc.
〒601-8023
45 Minamimatsunoki-cho, Higashikujo, Minami-ku, Kyoto 601−8023, JAPAN
+81-75-681-0787
©2025 BMG Inc.